Longitudinal analysis of nursing home residents' T cell responses after SARS-CoV-2 mRNA vaccinations shows influence of biological sex and SARS-CoV-2 infection history.

COVID-19 T cells booster geriatric long-term care mRNA vaccine

Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
14 May 2024
Historique:
received: 07 12 2023
revised: 02 04 2024
accepted: 28 04 2024
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 14 5 2024
Statut: aheadofprint

Résumé

Vaccines and vaccine boosting have blunted excess morbidity and mortality from SARS-CoV-2 infection suffered by older nursing home residents (NHR). However, the impact of repeated vaccination on the T cell response based on biological sex and prior infection of NHR remain understudied. We examined T cell responses to mRNA vaccines to SARS-CoV-2 in a cohort of NHR and healthcare workers (HCW) over 2 years. We used IFN-γ ELIspot and flow cytometry to assess T cell response before, two weeks and 6 months after the initial series and each of two booster vaccines. We analyzed these data longitudinally with mixed-effect modeling and also examined subsets of our cohorts for additional changes in T cell effector function. We show that prior SARS-CoV-2 infection and female sex contribute to higher T cell response in NHR but not HCW. When looking across time points, NHR but not HCW with prior infection had significantly higher T cell responses than infection-naive subjects. These patterns of response were maintained across multiple booster vaccinations and suggest that the age, multimorbidity, and/or frailty of the NHR cohort may accentuate sex and infection status differences in T cell response to mRNA vaccination.

Sections du résumé

BACKGROUND BACKGROUND
Vaccines and vaccine boosting have blunted excess morbidity and mortality from SARS-CoV-2 infection suffered by older nursing home residents (NHR). However, the impact of repeated vaccination on the T cell response based on biological sex and prior infection of NHR remain understudied.
METHODS METHODS
We examined T cell responses to mRNA vaccines to SARS-CoV-2 in a cohort of NHR and healthcare workers (HCW) over 2 years. We used IFN-γ ELIspot and flow cytometry to assess T cell response before, two weeks and 6 months after the initial series and each of two booster vaccines. We analyzed these data longitudinally with mixed-effect modeling and also examined subsets of our cohorts for additional changes in T cell effector function.
RESULTS RESULTS
We show that prior SARS-CoV-2 infection and female sex contribute to higher T cell response in NHR but not HCW. When looking across time points, NHR but not HCW with prior infection had significantly higher T cell responses than infection-naive subjects. These patterns of response were maintained across multiple booster vaccinations and suggest that the age, multimorbidity, and/or frailty of the NHR cohort may accentuate sex and infection status differences in T cell response to mRNA vaccination.

Identifiants

pubmed: 38743816
pii: 7672966
doi: 10.1093/infdis/jiae234
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Auteurs

Carson L Smith (CL)

Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Elise Didion (E)

Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Htin Aung (H)

Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Banumathi Tamilselvan (B)

Department of Nutrition, Case Western Reserve University, Cleveland, OH, USA.

Taissa Bej (T)

Geriatric Research, Education, and Clinical Center (GRECC), Louis Stokes VA Northeast Ohio Healthcare System, Cleveland, OH, USA.

Oladayo Oyebanji (O)

Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Carey L Shive (CL)

Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Geriatric Research, Education, and Clinical Center (GRECC), Louis Stokes VA Northeast Ohio Healthcare System, Cleveland, OH, USA.

Brigid M Wilson (BM)

Geriatric Research, Education, and Clinical Center (GRECC), Louis Stokes VA Northeast Ohio Healthcare System, Cleveland, OH, USA.
Case Western Reserve School of Medicine, Division of Infectious Diseases and HIV Medicine, Cleveland, OH, USA.

Mark Cameron (M)

Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.

Cheryl Cameron (C)

Department of Nutrition, Case Western Reserve University, Cleveland, OH, USA.

Stefan Gravenstein (S)

Division of Geriatrics and Palliative Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Center on Innovation in Long-Term Services and Supports, Providence Veterans Administration Medical Center, Providence, RI, USA.

David Canaday (D)

Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Geriatric Research, Education, and Clinical Center (GRECC), Louis Stokes VA Northeast Ohio Healthcare System, Cleveland, OH, USA.

Classifications MeSH